What the company does
Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with excision of …
What the weekly tape is saying
COPN closed the latest completed week at 69.90 CHF. The 4-week return is -8.3% and the 12-week return is -5.7%. Trend Signal is inactive, Market Dynamics is -1.24. Setup signature: Risk-first tape with a 19/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 91.39 CHF
- Vs Trend Line
- -23.5%
- Fair Value
- 63.06 CHF
- Vs Fair Value
- 10.8%
- 52W High
- 126.5 CHF
- 52W Low
- 52.22 CHF
- Drawdown
- -44.8%
- Range Position
- 23.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 33
- 52W Active Breadth
- 63.5%
- Sector Scope
- CH Healthcare
- Sector Rank
- 34 of 41
- Sector Percentile
- 17.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CH Healthcare
- Tracked Peers
- 41
- 4W Rank
- 34 of 41
- Avg 1W
- -0.6%
- Avg 4W
- 1.3%
- Trend Breadth
- 34.1%
- Positive MD
- 41.5%
CH Drug Manufacturers - General
- Tracked Peers
- 6
- 4W Rank
- 6 of 6
- Avg 1W
- 1.2%
- Avg 4W
- 4.8%
- Trend Breadth
- 33.3%
- Positive RS
- 66.7%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.24
- 4W MD Change
- -37.7%
- Relative Strength
- -16.57
- 4W RS Change
- -265.2%
- Expectation
- Undecided
- Probability
- 49.25%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 170.3K
- 13W Average
- 235.0K
- 52W Average
- 209.6K
- Vs 13W
- 0.7x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.0%
- 52W Volatility
- 8.8%
- Upside Weeks
- 28
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 5.9% / -5.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- EBS
- Country
- CH
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- CHF
- Market Cap
- 1.3B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 69.90 CHF | -4.0% | 91.39 CHF | 63.06 CHF | -1.24 | -16.57 | 170.3K | Off |
| 5 Jun 2026 | 72.80 CHF | -6.7% | 91.18 CHF | 62.89 CHF | -1.16 | -10.94 | 122.1K | Off |
| 29 May 2026 | 78.00 CHF | -0.1% | 90.79 CHF | 62.70 CHF | -1.06 | -5.46 | 132.5K | Off |
| 22 May 2026 | 78.10 CHF | 2.5% | 90.39 CHF | 62.48 CHF | -0.99 | -4.65 | 140.4K | Off |
| 15 May 2026 | 76.20 CHF | 4.1% | 90.03 CHF | 62.27 CHF | -0.90 | -4.54 | 187.8K | Off |
| 8 May 2026 | 73.20 CHF | -10.7% | 89.60 CHF | 62.08 CHF | -0.77 | -6.94 | 342.8K | Off |
| 1 May 2026 | 82.00 CHF | -9.5% | 89.33 CHF | 61.90 CHF | -0.75 | 4.52 | 200.8K | Off |
| 24 Apr 2026 | 90.60 CHF | -5.3% | 88.81 CHF | 61.70 CHF | -0.76 | 16.13 | 243.5K | On |
| 17 Apr 2026 | 95.63 CHF | 7.0% | 87.84 CHF | 61.42 CHF | -0.84 | 21.47 | 396.0K | On |
| 10 Apr 2026 | 89.38 CHF | 5.2% | 86.84 CHF | 61.13 CHF | -1.00 | 16.88 | 179.1K | Off |
| 3 Apr 2026 | 84.98 CHF | 8.4% | 86.06 CHF | 60.87 CHF | -1.02 | 13.94 | 245.8K | Off |
| 27 Mar 2026 | 78.42 CHF | 5.8% | 85.37 CHF | 60.64 CHF | -0.72 | 9.47 | 337.9K | Off |
| 20 Mar 2026 | 74.12 CHF | -12.9% | 84.80 CHF | 60.47 CHF | -0.30 | 6.29 | 356.2K | On |
| 13 Mar 2026 | 85.07 CHF | -19.0% | 84.22 CHF | 60.31 CHF | 0.29 | 17.85 | 405.6K | On |